99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: Different affinity between lytic and sclerotic bone metastases

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 12, 2003, Pages 1714-

  Garcia, J R ^a   Simo, M ^a   Perez, G ^a   Soler, M ^a   Lopez, S ^a   Setoain, X ^a   Lomena F ^a  

^a CETIR Unitat PET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MEDRONATE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; INTERMETHOD COMPARISON; LUNG CARCINOMA; OSTEOSCLEROSIS; POSITRON EMISSION TOMOGRAPHY; PROSTATE CARCINOMA; BONE TUMOR; CASE REPORT; CLASSIFICATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; LUNG TUMOR; MALE; METASTASIS; METHODOLOGY; PROSTATE TUMOR; SCINTISCANNING;

BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0347364781     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1370-3     Document Type: Article

References (2)

1. O'Sullivan JM, Cook GJ. A review of the efficacy of bone scanning in prostate and breast cancer. Q J Nucl Med 2002; 46:152-159.
2. 99mTc-HMDP bone scan and F-18 FDG positron emission tomographic images in a patient with small cell lung cancer. Clin Nucl Med 2003; 28:232-233.